Cargando…
Pranlukast reduces asthma exacerbations during autumn especially in 1- to 5-year-old boys
BACKGROUND: Leukotriene receptor antagonists have been used to prevent virus-induced asthma exacerbations in autumn. Its efficacy, however, might differ with age and sex. OBJECTIVE: This study aimed to investigate whether pranlukast added to usual asthma therapy in Japanese children during autumn, s...
Autores principales: | Morita, Yoshinori, Campos Alberto, Eduardo, Suzuki, Shuichi, Sato, Yoshinori, Hoshioka, Akira, Abe, Hiroki, Saito, Kimiyuki, Tsubaki, Toshikazu, Haraki, Mana, Sawa, Akiko, Nakayama, Yoshio, Kojima, Hiroyuki, Shigeta, Midori, Yamaide, Fumiya, Kohno, Yoichi, Shimojo, Naoki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia Pacific Association of Allergy, Asthma and Clinical Immunology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287065/ https://www.ncbi.nlm.nih.gov/pubmed/28154801 http://dx.doi.org/10.5415/apallergy.2017.7.1.10 |
Ejemplares similares
-
195 The Impact of Administration of Leukotriene Receptor Antagonists, Pranlukast-EK to Infants with Bronchial Asthma
por: Ogawa, Norifumi, et al.
Publicado: (2012) -
82 Association of Matrix Metalloproteinase-7 and -12 Genes polymorphisms With Asthma: A Case-Control Study of MMP-7 and -12 in a Japanese Population
por: Yamaide, Fumiya, et al.
Publicado: (2012) -
Early use of alendronate as a protective factor against the development of glucocorticoid-induced bone loss in childhood-onset rheumatic diseases: a cross-sectional study
por: Inoue, Yuzaburo, et al.
Publicado: (2018) -
Metabolite Dysregulation by Pranlukast in Mycobacterium tuberculosis
por: Yelamanchi, Soujanya D., et al.
Publicado: (2022) -
Efficacy and Safety of Modified Pranlukast (Prakanon(®)) Compared with Pranlukast (Onon(®)): A Randomized, Open-Label, Crossover Study
por: Kim, Seo W., et al.
Publicado: (2016)